Exane Derivatives’s Horizon Bancorp HBNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$3.6K Sell
207
-919
-82% -$16.4K ﹤0.01% 403
2022
Q1
$21K Buy
+1,126
New +$23.3K 0.01% 661

Other funds holding HBNC

Exane Derivatives's HBNC Position: Q2 2022 in Review

Exane Derivatives reduced its Horizon Bancorp (HBNC) stake by 82% in Q2 2022, selling an estimated $16.4K and leaving 207 shares worth $3.6K. The position accounts for ﹤0.01% of the portfolio, ranked #403.

Exane Derivatives first reported a position in HBNC in Q1 2022 and has held it in 2 quarters since. The position peaked at $21K in Q1 2022. 155 funds tracked by Wall St. Rank hold HBNC as of Q2 2022.

  • Exane Derivatives held 207 shares of Horizon Bancorp worth $3.6K as of Q2 2022.
  • Exane Derivatives sold 919 Horizon Bancorp shares in Q2 2022, an estimated $16.4K.
  • Horizon Bancorp made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #403 holding.
  • Exane Derivatives first reported a position in Horizon Bancorp in Q1 2022 and has held it in 2 quarters since.
  • Exane Derivatives's Horizon Bancorp position peaked at $21K in Q1 2022.
  • 155 funds tracked by Wall St. Rank held Horizon Bancorp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.